Safety and efficacy of nivolumab in patients who failed to achieve a complete remission after CD19-directed CAR T-cell therapy in diffuse large B cell lymphoma.

Nicolas GazeauSuman MitraMorgane NudelRemi TilmontPaul ChauvetMicha SrourAnne-Sophie MoreauPauline VarletEnagnon Kazali AlidjinouSalomon ManierFranck MorschhauserMyriam LabaletteIbrahim Yakoub-AghaDavid Beauvais

Published in: British journal of haematology (2023)

Keyphrases

diffuse large b cell lymphoma
cell therapy
epstein barr virus
stem cells
mesenchymal stem cells
disease activity
ulcerative colitis
nk cells
rheumatoid arthritis